2-202542318-C-T
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_ModerateBP6_StrongBP7BS2
The NM_001204.7(BMPR2):c.1284C>T(p.Ser428Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000114 in 1,613,656 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★★).
Frequency
Consequence
NM_001204.7 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -11 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BMPR2 | ENST00000374580.10 | c.1284C>T | p.Ser428Ser | synonymous_variant | Exon 10 of 13 | 1 | NM_001204.7 | ENSP00000363708.4 | ||
BMPR2 | ENST00000374574.2 | c.1284C>T | p.Ser428Ser | synonymous_variant | Exon 10 of 12 | 2 | ENSP00000363702.2 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 151980Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000477 AC: 12AN: 251370Hom.: 0 AF XY: 0.0000662 AC XY: 9AN XY: 135892
GnomAD4 exome AF: 0.000120 AC: 175AN: 1461676Hom.: 0 Cov.: 31 AF XY: 0.000124 AC XY: 90AN XY: 727158
GnomAD4 genome AF: 0.0000592 AC: 9AN: 151980Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74226
ClinVar
Submissions by phenotype
Pulmonary arterial hypertension Uncertain:1
NM_001204.7(BMPR2):c.1284C>T (p.Ser428Ser) The BMPR2 c.1284C>T variant is a synonymous (silent) variant that is not predicted by SpliceAI to impact splicing.The highest population minor allele frequency in gnomAD v2.1.1 controls is 0.072% (3/4154 alleles) in the Estonian population, which is lower than the ClinGen Pulmonary Hypertension VCEP threshold of >0.1% for BS1 and >1% for BA1, and higher than the ClinGen Pulmonary Hypertension VCEP threshold of <0.01% for PM2. Neither BS1, BA1 nor PM2 are met. BS2 was not met as the variant was not observed as a homozygous allele in gnomAD v2.1.1 controls. Neither BP4 nor PP3 were met based on the computational predictor, CADD, giving a score of 11.4 which is above the threshold of <=10.0 for BP4 and below the threshold of >=20 for PP3. Due to the absence of segregation data PP1, PM6 and PS2 could not be evaluated. Due to absence of functional data PS3 could not be evaluated. In summary, the variant meets the criteria to be classified as a variant of uncertain significance for pulmonary arterial hypertension based on the ACMG/AMP criteria applied, as specified by the ClinGen Pulmonary Hypertension VCEP: BP7 (VCEP specification version 1.1, 1/18/2024). -
Pulmonary hypertension, primary, 1 Uncertain:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Primary pulmonary hypertension Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at